161 related articles for article (PubMed ID: 8850464)
41. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
Baas P; Murrer L; Zoetmulder FA; Stewart FA; Ris HB; van Zandwijk N; Peterse JL; Rutgers EJ
Br J Cancer; 1997; 76(6):819-26. PubMed ID: 9310252
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.
Melnikova VO; Bezdetnaya LN; Brault D; Potapenko AY; Guillemin F
Int J Cancer; 2000 Dec; 88(5):798-803. PubMed ID: 11072251
[TBL] [Abstract][Full Text] [Related]
44. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma.
Ris HB
Lung Cancer; 2005 Jul; 49 Suppl 1():S65-8. PubMed ID: 15916831
[TBL] [Abstract][Full Text] [Related]
45. Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3.
van der Snoek EM; den Hollander JC; Aans JB; Sterenborg HJ; van der Ende ME; Robinson DJ
Lasers Surg Med; 2012 Oct; 44(8):637-44. PubMed ID: 22899359
[TBL] [Abstract][Full Text] [Related]
46. Non-metastatic cutaneous squamous cell carcinoma treated with photodynamic therapy using intravenous mTHPC.
Jerjes W; Yousif AA; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2019 Dec; 28():172-176. PubMed ID: 31394299
[TBL] [Abstract][Full Text] [Related]
47. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.
Hopper C; Kübler A; Lewis H; Tan IB; Putnam G
Int J Cancer; 2004 Aug; 111(1):138-46. PubMed ID: 15185355
[TBL] [Abstract][Full Text] [Related]
48. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
49. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster.
Mlkvy P; Messmann H; Pauer M; Stewart JC; Millson CE; MacRobert AJ; Bown SG
Br J Cancer; 1996 Jun; 73(12):1473-9. PubMed ID: 8664115
[TBL] [Abstract][Full Text] [Related]
50. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Peng Q; Moan J; Ma LW; Nesland JM
Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
[TBL] [Abstract][Full Text] [Related]
51. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947
[TBL] [Abstract][Full Text] [Related]
52. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
[TBL] [Abstract][Full Text] [Related]
53. Foscan uptake and tissue distribution in relation to photodynamic efficacy.
Cramers P; Ruevekamp M; Oppelaar H; Dalesio O; Baas P; Stewart FA
Br J Cancer; 2003 Jan; 88(2):283-90. PubMed ID: 12610515
[TBL] [Abstract][Full Text] [Related]
54. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
55. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.
Garrier J; Bressenot A; Gräfe S; Marchal S; Mitra S; Foster TH; Guillemin F; Bezdetnaya L
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):563-71. PubMed ID: 20656417
[TBL] [Abstract][Full Text] [Related]
56. In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
Blant SA; Woodtli A; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Photochem Photobiol; 1996 Dec; 64(6):963-8. PubMed ID: 8972639
[TBL] [Abstract][Full Text] [Related]
57. Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma.
Schouwink H; Baas P
Ann Thorac Surg; 2004 Jul; 78(1):388; author reply 388-9. PubMed ID: 15223483
[No Abstract] [Full Text] [Related]
58. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study.
Baas P; Saarnak AE; Oppelaar H; Neering H; Stewart FA
Br J Dermatol; 2001 Jul; 145(1):75-8. PubMed ID: 11453910
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins.
van Doeveren TEM; Karakullukçu MB; van Veen RLP; Lopez-Yurda M; Schreuder WH; Tan IB
Laryngoscope; 2018 Mar; 128(3):657-663. PubMed ID: 28786113
[TBL] [Abstract][Full Text] [Related]
60. mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
de Visscher SA; Dijkstra PU; Tan IB; Roodenburg JL; Witjes MJ
Oral Oncol; 2013 Mar; 49(3):192-210. PubMed ID: 23068024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]